Page 2 - Nasdaq Pcrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq pcrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Pcrx Today - Breaking & Trending Today

AIA Group Ltd Buys 11,198 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX)

AIA Group Ltd increased its stake in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 21.1% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 64,391 shares of the company’s stock after purchasing an additional 11,198 shares during the quarter. AIA Group Ltd’s holdings in Pacira BioSciences were worth $1,976,000 at the end […] ....

United States , Raymond James , Pacira Biosciences , Needham Company , Rice Hall James Associates , Raymond James Associates , Aia Group Ltd , Group Ltd , Metlife Investment Management , Pacira Biosciences Inc , Raymond James Financial Services Advisors Inc , Free Report , Hall James , James Financial Services Advisors , Life Investment Management , Biosciences Stock Down , Get Free Report , Visit Holdingschannel , Pacira Biosciences Daily , Nasdaq Pcrx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Pacira BioSciences (NASDAQ:PCRX) Shares Gap Up to $31.47

Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report)’s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $31.47, but opened at $32.16. Pacira BioSciences shares last traded at $32.72, with a volume of 52,474 shares trading hands. Analyst Upgrades and Downgrades A number of research firms have […] ....

United States , Raymond James , Pacira Biosciences , Gradient Investments , Needham Company , Keybank National Association , Pacira Biosciences Inc , Silvercrest Asset Management Group , Royal Bank , Rice Hall James Associates , Get Free Report , Asset Management Group , National Association , Rice Hall James , Hall James , Pacira Biosciences Daily , Nasdaq Pcrx ,

Pacira BioSciences, Inc. (NASDAQ:PCRX) Stock Position Raised by Rock Springs Capital Management LP

Rock Springs Capital Management LP raised its position in shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) by 0.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,035,000 shares of the company’s stock after purchasing an additional 2,400 shares during […] ....

United States , Piper Sandler , Pacira Biosciences , Exchange Commission , Pacira Biosciences Inc , Rice Hall James Associates , Needham Company , Royal Bank , Raymond James Financial Services Advisors Inc , Metlife Investment Management , Raymond James Associates , Rock Springs Capital Management , Free Report , Springs Capital Management , Hall James , James Financial Services Advisors , Life Investment Management , Get Free Report , Visit Holdingschannel , Pacira Biosciences Daily , Nasdaq Pcrx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the nine analysts that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 1-year target […] ....

United States , Pacira Biosciences , Stephens Inc , Metlife Investment Management , Pacira Biosciences Inc , Ameritas Investment Partners Inc , First National Bank , Needham Company , Pacira Biosciences Company Profile , Get Free Report , Marketbeat Ratings , National Bank , Investment Partners , Life Investment Management , Arizona State Retirement System , State Retirement System , Get Free , Pacira Biosciences Daily , Nasdaq Pcrx ,

Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Average Rating of "Moderate Buy" by Brokerages

Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) has earned an average rating of “Moderate Buy” from the nine research firms that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average twelve-month target […] ....

United States , Piper Sandler , Pacira Biosciences , China Universal Asset Management Co , Pacira Biosciences Company Profile , Financial Freedom , Group Wealth Management , R Capital Management Inc , Needham Company , Pacira Biosciences Inc , Get Free Report , Ivy Capital Management , Wealth Management , China Universal Asset Management , Universal Asset Management , Get Free , Pacira Biosciences Daily , Nasdaq Pcrx ,